We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-12.47%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$1.72B
AUM Growth
-$237M
Cap. Flow
+$240M
Cap. Flow %
13.91%
Top 10 Hldgs %
74.83%
Holding
51
New
2
Increased
2
Reduced
5
Closed
–

Top Buys

Rank Stock Value
1
PRME icon
Prime Medicine
PRME
+$240M
2
CRWD icon
CrowdStrike
CRWD
+$85.2M
3
GTLB icon
GitLab
GTLB
+$31.7M
4
EQRX
EQRx, Inc. Common Stock
EQRX
+$484K

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$82.3M
2
VLD
Velo3D, Inc.
VLD
+$12M
3
VERV
Verve Therapeutics
VERV
+$11.3M
4
LYFT icon
Lyft
LYFT
+$10.6M
5
RANI icon
Rani Therapeutics
RANI
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 54.09%
2 Technology 31.93%
3 Industrials 9%
4 Financials 2.36%
5 Consumer Staples 2.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERA icon
26
Vera Therapeutics
VERA
$2.53B
$5.84M 0.34%
301,580
– –
NEWR
27
DELISTED
New Relic, Inc.
NEWR
$5.14M 0.3%
91,132
– –
BRNS
28
Barinthus Biotherapeutics
BRNS
$24.6M
$3.56M 0.21%
1,513,644
– –
DBTX
29
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$3.35M 0.19%
1,636,258
– –
FHTX icon
30
Foghorn Therapeutics
FHTX
$305M
$3.2M 0.19%
500,901
– –
RANI icon
31
Rani Therapeutics
RANI
$91M
$3.01M 0.17%
510,128
-204,343
-29% -$1.49M
KRON
32
DELISTED
Kronos Bio
KRON
$2.33M 0.14%
1,438,232
– –
AMPL icon
33
Amplitude
AMPL
$1.15B
$2.29M 0.13%
189,447
– –
FULC icon
34
Fulcrum Therapeutics
FULC
$249M
$1.86M 0.11%
255,452
– –
TNYA icon
35
Tenaya Therapeutics
TNYA
$167M
$1.84M 0.11%
915,705
– –
EVLO
36
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$1.71M 0.1%
53,025
– –
TCRX icon
37
TScan Therapeutics
TCRX
$50.2M
$1.65M 0.1%
1,077,080
– –
ALEC icon
38
Alector
ALEC
$168M
$1.62M 0.09%
175,866
– –
SPRO icon
39
Spero Therapeutics
SPRO
$68.3M
$1.54M 0.09%
889,979
– –
TSHA icon
40
Taysha Gene Therapies
TSHA
$1.59B
$1.45M 0.08%
640,882
– –
SNCE
41
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$1.35M 0.08%
160,363
– –
DNTH icon
42
Dianthus Therapeutics
DNTH
$5.71B
$1.34M 0.08%
208,696
– –
AUTL
43
Autolus Therapeutics
AUTL
$389M
$1.33M 0.08%
698,262
– –
EXAS
44
DELISTED
Exact Sciences
EXAS
$1.15M 0.07%
23,205
– –
VLD
45
DELISTED
Velo3D, Inc.
VLD
$1.02M 0.06%
16,354
-123,646
-88% -$12M
HYPR icon
46
Hyperfine
HYPR
$95.3M
$755K 0.04%
898,720
– –
OPRT icon
47
Oportun Financial
OPRT
$262M
$522K 0.03%
94,788
– –
NVTA
48
DELISTED
Invitae Corporation
NVTA
$402K 0.02%
215,965
– –
QNCX icon
49
Quince Therapeutics
QNCX
$17.5M
$121K 0.01%
946
– –
RGEN icon
50
Repligen
RGEN
$7.39B
$64.8K ﹤0.01%
383
– –
1
2
3

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q4 2022 Portfolio in Review

As of Q4 2022, Alphabet Inc held 51 positions worth $1.72B, down 12% from $1.96B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Alphabet Inc deployed $240M of net new capital in Q4 2022, opening 2 new positions and adding to 2 existing holdings. Its largest new stake was Prime Medicine: 13,284,688 shares worth $247M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 58% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was DexCom, an estimated $82.3M trimmed.

  • Alphabet Inc's largest Q4 2022 buy was Prime Medicine: 13,284,688 shares worth $247M.
  • Alphabet Inc added most to GitLab in Q4 2022, an estimated $31.7M increase.
  • Alphabet Inc's biggest Q4 2022 reduction was DexCom, cutting an estimated $82.3M.
  • Alphabet Inc's ten largest holdings make up 75% of its $1.72B portfolio in Q4 2022.
  • Alphabet Inc opened 2 new positions and closed 0 in Q4 2022.
  • Alphabet Inc's portfolio value fell 12% quarter-over-quarter to $1.72B.

Based on Alphabet Inc's 13F filing for Q4 2022, filed 14 Feb 2023.